§ BIOTECHNOLOGY
USD · BiotechnologyCYTK
CYTOKINETICS INC
USDSector · BiotechnologyBeta · 0.43
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
340 increased/new, 116 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 15.68 | EPS (TTM) | -6.53 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 16.5M | 0.0% | +1% |
| Fidelity Management | 10.7M | 0.0% | −16% |
| WELLINGTON MANAGEMENT GROUP LLP | 8.0M | 0.1% | +1% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.8M | n/a | n/a |
| State Street | 5.7M | 0.0% | −1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.5M | n/a | n/a |
◇ AC INTELLIGENCE
Top institutional owners for CYTK as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER75.1% · 337 holders
PASSIVE / INDEX18.6% · 12 holders
DEALER / BANK17.0% · 38 holders
QUALITY / COMPOUNDER16.9% · 29 holders
TACTICAL / MACRO2.6% · 5 holders
INCOME / DEFENSIVE2.0% · 24 holders
SYSTEMATIC / QUANT1.5% · 6 holders
ACTIVIST0.6% · 1 holder
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for CYTK in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention CYTK yet.